Tag: Harvoni

With a sustained virologic response (SVR) rate exceeding 95% in many cases, Harvoni has revolutionized Hepatitis C treatment. While the medication is highly effective and generally well-tolerated during treatment, understanding **what are the long-term side effects of taking Harvoni** is crucial for patients with pre-existing liver damage or co-existing conditions.

Harvoni, a combination of the direct-acting antivirals ledipasvir and sofosbuvir, can be given for a duration of 8 to 24 weeks, depending on the patient's specific health profile. This advanced medication revolutionized hepatitis C treatment by offering high cure rates with a once-daily, single-tablet regimen.

Initially approved by the FDA in 2014, Harvoni was a landmark hepatitis C treatment offering cure rates of over 90% for specific genotypes. While newer, more versatile direct-acting antivirals (DAAs) have since emerged, the question remains: **is Harvoni still used** in current medical practice? The answer is yes, though its place in therapy has evolved.

Globally, an estimated 50 million people have chronic hepatitis C [1.3.3]. The question 'What is the miracle drug for hep C?' points not to a single pill, but to a revolutionary class of drugs called Direct-Acting Antivirals (DAAs) that can cure more than 95% of cases [1.3.3].

Recent years have seen a revolution in hepatitis C (HCV) treatment, with direct-acting antivirals (DAAs) now able to cure over 95% of cases. This has led many to wonder: what is the Hep C pill called? The answer is that there isn't just one pill, but a range of highly effective oral medications that target the virus directly.

Over 90% of people with chronic hepatitis C virus (HCV) can be cured with direct-acting antiviral (DAA) medications. Among these, Harvoni Tablet is used to treat specific genotypes of HCV infection in adults and certain children.